Acumen Research and Consulting recently published report titled “Anesthesia & Respiratory Devices Market Share, Analysis Report and Region Forecast, 2022 – 2030”
LOS ANGELES, Sept. 26, 2022 (GLOBE NEWSWIRE) — The Global Anesthesia & Respiratory Devices Market Size accounted for USD 28.3 Billion in 2021 and is estimated to garner a market size of USD 49.9 Billion by 2030 rising at a CAGR of 6.5% from 2022 to 2030. Anesthesia & Respiratory Devices Market Statistics
Global anesthesia & respiratory devices market value was USD 28.3 Billion in 2021 and expected to grow at CAGR of 6.5% from 2022 to 2030
According to the WHO, 262 million people suffer from asthma in the world
North America anesthesia & respiratory devices market share will gather around 30% market share in coming years
Asia-Pacific anesthesia & respiratory devices market growth recorded substantial CAGR during the forecast timeframe from 2022 to 2030
Among products, respiratory devices sub-segment collected over 65% of the overall market share in 2021
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/2529
Anesthesia & Respiratory Devices Market Report Coverage:
Market
Anesthesia & Respiratory Devices Market
Anesthesia & Respiratory Devices Market Size 2021
USD 28.3 Billion
Anesthesia & Respiratory Devices Market Forecast 2030
USD 49.9 Billion
Anesthesia & Respiratory Devices Market CAGR During 2022 – 2030
6.5%
Anesthesia & Respiratory Devices Market Analysis Period
2018 – 2030
Anesthesia & Respiratory Devices Market Base Year
2021
Anesthesia & Respiratory Devices Market Forecast Data
2022 – 2030
Segments Covered
By Product, By End-User, And By Geography
Anesthesia & Respiratory Devices Market Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled
CAIRE Inc., B. Braun Medical Inc., Becton, Dickinson and Company, Medtronic plc, Drägerwerk AG, Getinge AB., GE Healthcare, Koninklijke Philips N.V., and Teleflex Incorporated.
Report Coverage
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Anesthesia & Respiratory Devices Market Growth Factors
Rising base of preterm births
Increasing volume of surgical procedures
Rising prevalence of respiratory disorders
Rise in elderly population
Anesthesia & Respiratory Devices Market Dynamics
The increasing prevalence of end-stage renal disease (ESRD), advanced technologies, and a boost in cost-effective and accurate portable dialysis devices are driving the global market for anesthesia and respiratory devices. According to estimates published in 2018 by the University of California San Francisco, an estimated 2 million people worldwide have ESRD. As the disease becomes more prevalent in the patient population, the demand for anesthesia and respiratory devices more than doubles. As a result, there is an increasing demand for a rapid yet efficient treatment option for the disease-ridden population.
Anesthesia & Respiratory Devices Business Strategies
In April 2018, B. Braun Medical Inc. announced the approval of its first FDA-approved local anaesthetics for spinal anesthesia product, “Clorotekal® (chloroprocaine hydrochloride).” Clorotekal (chloroprocaine hydrochloride) is recommended for intrathecal injection in adults to produce subarachnoid block (spinal anesthesia) and is indicated for procedures requiring a short duration of action.
In June 2018, Getinge AB announced the release of its “Flow-c anesthesia machine.” The Flow-c ensures superior ventilation rates with the power and precision required to ventilate all patient categories, based on the world-class Servo ventilator console and the same innovative technology as the Flow-1. Furthermore, the newly released product is designed to simplify daily anesthesia workflow in a fast-paced environment.
In September 2019, Biovo Technologies Ltd. introduced “Hyper Form,” a game-changing technology that solves the main issue with the sealing cuff element that plagues current products (currently known as CleanSweep®) acquired by Teleflex and the newly launched Cuffix.
Check the detailed table of contents of the report @
https://www.acumenresearchandconsulting.com/table-of-content/anesthesia-and-respiratory-devices-market
Anesthesia & Respiratory Devices Market Segmentation
Anesthesia and respiratory devices are broadly classified based on product and end-user. The market is divided into two categories: anesthesia devices and respiratory devices. Machines and disposables are the two types of anesthesia devices. Delivery machines, ventilators, monitors, and workstations are all subcategories of machines. Disposable masks and disposable accessories are two types of disposables. In addition, respiratory devices are classified as equipment, disposables, or measurement devices. Positive airway pressure, humidifiers, ventilators, inhalers, nebulizers, oxygen concentrators, and reusable resuscitators are all types of equipment. Disposable oxygen masks, resuscitators, tracheotomy tubes, and oxygen cannulae are all types of disposables. Pulse oximeters, spirometers, capnography, and peak flow metres are the different types of measurement devices. The market is divided into four end-user segments: hospitals, clinics, home care settings, and ambulatory service centers.
Anesthesia & Respiratory Devices Market Share
According to product segment, respiratory devices will have the largest market share accounting for over 65% in the coming years. The growing number of patients suffering from respiratory diseases, the increased number of procedures performed on patients, and increasing healthcare costs are all encouraging factors for the utmost shares for anesthesia and respiratory devices. Furthermore, due to the high number of surgeries performed on patients, anesthesia devices are anticipated to have a substantial growth rate in the coming years, resulting in high growth for anesthesia and respiratory devices globally.
Anesthesia & Respiratory Devices Market Regional Growth
North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa comprise the global anesthesia & respiratory devices industry (MEA). North America had the highest market share in 2021 and is expected to maintain this trend in the coming years, resulting in anesthesia and respiratory device market growth. The presence of prominent players in this region, the widespread adoption of technically sophisticated products and devices, rising investment by medical device companies, and rising healthcare expenditure are all factors contributing to the global market for anesthesia and respiratory devices growth. Furthermore, Japan has the largest market share in the APAC regional market for anesthesia and respiratory devices. Furthermore, India and China contribute significantly to the global growth of the anesthesia and respiratory device markets.
Buy this premium research report –
https://www.acumenresearchandconsulting.com/buy-now/0/2529
Anesthesia & Respiratory Devices Market Players
Some of the leading anesthesia & respiratory devices companies operating in the industry include B. Braun Medical Inc., Becton, Dickinson and Company, CAIRE Inc., Drägerwerk AG, GE Healthcare, Getinge AB., Medtronic plc, Koninklijke Philips N.V., Teleflex Incorporated., and among others.
Questions Answered By This Report
What was the market size of Anesthesia & Respiratory Devices Market in 2021?
What will be the CAGR of Anesthesia & Respiratory Devices Market during the forecast period from 2022 to 2030?
Who are the major players in Global Anesthesia & Respiratory Devices Market?
Which region held the largest share in Anesthesia & Respiratory Devices Market in 2021?
What are the key market drivers of Anesthesia & Respiratory Devices Market?
Who is the largest end user Anesthesia & Respiratory Devices Market?
What will be the Anesthesia & Respiratory Devices Market value in 2030?
Browse More Research Topic on Informatics Related:
The Worldwide Medical Pendant Market accounted for USD 466 Million in 2021 and is expected to hit USD 830 Million by 2030, with a significant CAGR of 6.7% from 2022 to 2030.
The Global Super Absorbent Dressings Market accounted for USD 95 Million in 2021 and is expected to reach USD 141 Million by 2030 with a considerable CAGR of 4.5% during the forecast timeframe of 2022 to 2030.
The Worldwide Colposcopy Market accounted for USD 455 Million in 2021 and is expected to hit USD 711 Million by 2030, with a significant CAGR of 5.3% from 2022 to 2030.
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter and, LinkedIn
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com
Exxon is arguing against the push to get energy companies to slow overseas shipments and stash more fuel in storage tanks.
When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.
(Bloomberg) — Storm clouds are forming in the North American aluminum market as makers of everything from automobiles to beverage cans to kitchen appliances are holding off booking next year’s raw material orders.Most Read from BloombergGazprom Halts Gas Supplies to Italy in Latest Energy BattleFed Begins to Split on the Need for Speed to Peak RatesIndonesia Suspends Football Matches as Riot Kills at Least 129Get Ready for Another Bear-Market Rally, Strategist Emanuel SaysUkraine Latest: US See
Charles River Laboratories is a pharmaceutical company that specializes in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services. The cutting-edge Massachusetts-based company has been upgraded to a fundamental "buy" recommendation by a sell-side firm with a $240 price target. In the daily bar chart of CRL, below, we can see that the shares have been in a steady downtrend the past 12 months.
NEW DELHI (Reuters) -An Indian appellate authority has confirmed a seizure order against Chinese smartphone maker Xiaomi Corp that froze $682 million in an investigation related to illegal remittances to foreign entities, authorities said on Friday. India's federal financial crime fighting agency, the Enforcement Directorate, seized 55.51 billion rupees in April, saying a probe found the company had made illegal remittances to foreign entities by passing them off as royalty payments. "Under the cover of various unrelated documentary facade created amongst the group entities, the company remitted this amount in guise of royalty abroad," which violated India's foreign exchange laws, the agency said on Friday.
Yahoo Finance's Akiko Fujita discusses Geely's purchase of Aston Martin stock.
(Bloomberg) — Saudi Arabia is budgeting for Brent oil at around $76 a barrel next year, according to Al Rajhi Capital, an outlook in line with current forward prices but far more bearish than expected by analysts.Most Read from BloombergGazprom Halts Gas Supplies to Italy in Latest Energy BattleFed Begins to Split on the Need for Speed to Peak RatesIndonesia Suspends Football Matches as Riot Kills at Least 129Get Ready for Another Bear-Market Rally, Strategist Emanuel SaysUkraine Latest: US See
If Nike and VF are struggling into the fall, there are a host of others about to feel the pinch.
(Bloomberg) — New-car sales are expected to rise in the just-ending third quarter, but a deteriorating market for used vehicles — which sent CarMax Inc. shares tumbling Thursday — suggests trouble ahead for automakers.Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandTop Apple Executive Is Leaving After Making Crude Remarks in TikTok VideoMeta to Cut Headcount for First Time, Slash Budgets Across TeamsMarjorie Taylor Greene’s Husband Files for Divorce After
U.S. energy firms this week added oil and natural gas rigs for a third week in a row, but growth in the third quarter slowed due to recession fears and nagging supply shortages. The oil and gas rig count, an early indicator of future output, rose one to 765 in the week to Sept. 30, energy services firm Baker Hughes Co said in its closely followed report on Friday. Baker Hughes said that puts the total rig count up 237, or 45%, over this time last year.
In the future, your choice of smartphone ecosystem—Android or iPhone—could determine which make and model of car you choose.
Pure Storage (PSTG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rail is never oil producers’ first choice, but a new transcontinental line could become the most attractive backup option when pipelines fail.
(Bloomberg) — Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandMeta to Cut Headcount for First Time, Slash Budgets Across TeamsTop Apple Executive Is Leaving After Making Crude Remarks in TikTok VideoStocks Plummet to 22-Month Low as Fed Hawks Circle: Markets WrapMarjorie Taylor Greene’s Husband Files for Divorce After 27 YearsAmerican companies have had a growing list of reasons to downgrade their ties with China in recent years. Former President Donald Tru
Invesco Investment Solutions Senior Portfolio Manager Alessio de Longis joins Yahoo Finance Live to discuss the likelihood of a global recession, market uncertainty, rising bond yields, the tech sector, and the outlook for the economy.
UnitedHealth Group stock has been outperforming for months as it ignores the weakness in the broader market averages. Previous tests of the 200-day moving average line were buying opportunities in October and May and June. UNH is again testing the rising 200-day line but the result could be different — the trading volume has increased in September as prices pulled back and this could be a sign that traders are voting with their feet.
Just when we thought Americans were going to get some relief from high prices at the pump, Californians got hit hard with a jump. As of Sept. 30, California is paying an average of $6.29 — much…
Pandemic-led sluggish enterprise IT spending has clouded the outlook of the Zacks Computers – IT Services Industry. However, the solid uptake of digital remote-working solutions makes things rosy for companies like CDW, EPAM Systems (EPAM) and Nutanix (NTNX).
No one ever accused September of being a strong month for the market, and that's still true. Here's why we closed out Nucor and trimmed AMD, while building up PepsiCo and buying into Lockheed Martin.
A comprehensive trade deal between India and the European Union could pave the way for Mercedes-Benz to produce more cars in the South Asian nation, potentially making it an export hub, Mercedes' country head told Reuters on Friday. In June, the EU and India relaunched talks for a free trade agreement with the aim of completing them by the end of 2023. Talks began in 2007, but were frozen in 2013 due to lack of progress on issues including EU demands for greater access to Indian markets for its cars.